Registration of securities issued in business combination transactions

Stockholders??? Equity (Deficit) (Tables)

v3.23.3
Stockholders’ Equity (Deficit) (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Stockholders' Equity Note [Abstract]    
Schedule of Stock Warrants   The following table summarizes our warrants outstanding as of the dates presented:
 

Exercise
Price

 

Expiration
Date

 

Balance as of
December 31,
2021

 

Issued

 

Exercised

 

Expired

 

Balance as of
December 31,
2022

2019 Public Warrants(1)

 

$

230.00

 

6/19/2024

 

5,813,804

 

 

 

 

 

5,813,804

2022 Unit Offering

 

 

                 

 

       

Pre-funded Warrants(2)

 

$

0.002

 

6/29/2027

 

 

14,095,400

 

(14,095,400

)

 

 

Common Warrants(3)

 

$

4.60

 

6/29/2027

 

 

43,478,261

 

 

 

 

43,478,261

Underwriter Warrants(3)

 

$

4.60

 

6/29/2027

 

 

2,173,913

 

 

 

 

2,173,913

   

 

       

5,813,804

 

59,747,574

 

(14,095,400

)

 

 

51,465,978

(1)      The 2019 Public Warrants are exercisable for 290,690 shares of Common Stock at $230.00 per share or a ratio of 20 warrants for one share of Common Stock.

(2)      A total of 14,095,400 Pre-funded Warrants were issued and exercised in exchange for 704,770 shares of Common Stock.

(3)      The Common Warrants and Underwriter Warrants are exercisable for a combined amount of 2,282,609 shares of Common Stock at $4.60 per share or a ratio of 20 warrants for one share of Common Stock.

Schedule of Warrants Outstanding The following table summarizes our warrants outstanding as of the dates presented:
 

Exercise
Price

 

Expiration
Date

 

Balance as of
December 31,
2022

 

Issued

 

Exercised

 

Expired

 

Balance as of
September 30,
2023

2019 Public Warrants(1)

 

$

230.00

 

6/19/2024

 

5,813,804

 

 

 

 

5,813,804

2022 Unit Offering

 

 

                         

Common Warrants(2)

 

$

0.37

 

6/29/2027

 

43,478,261

 

 

 

 

43,478,261

Underwriter Warrants(2)

 

$

0.37

 

6/29/2027

 

2,173,913

 

 

 

 

2,173,913

   

 

       

51,465,978

 

 

 

 

51,465,978

(1)      The 2019 Public Warrants are exercisable for 290,690 shares of Common Stock at $230.00 per share or a ratio of 20 warrants for one share of Common Stock.

(2)      In connection with the PIPE Investment, the exercise price of the Common Warrants and Underwriter Warrants was reduced from $0.88 per shares to $0.37 per share and are exercisable for a combined amount of 2,282,609 shares of Common Stock at $0.37 per share or a ratio of 20 warrants for one share of Common Stock.